05 / Evaluation of safe medication practice in our Hospital. SUMA project

Author(s):  
Carlos Martinez Villar
2013 ◽  
Vol 102 (5) ◽  
pp. 532-538 ◽  
Author(s):  
Kristina Star ◽  
Karin Nordin ◽  
Ulrika Pöder ◽  
I Ralph Edwards

2017 ◽  
Vol 34 (1) ◽  
pp. 4-7 ◽  
Author(s):  
David Whitaker ◽  
Guttorm Brattebø ◽  
Stefan Trenkler ◽  
Indulis Vanags ◽  
Flavia Petrini ◽  
...  

2008 ◽  
Vol 42 (4) ◽  
pp. 427-431 ◽  
Author(s):  
Ian D Coombes ◽  
Charles A Mitchell ◽  
Danielle A Stowasser

2007 ◽  
Vol 4 (3) ◽  
pp. 128-134 ◽  
Author(s):  
Ian Coombes ◽  
Charles Mitchell ◽  
Danielle Stowasser

Author(s):  
Steven B. Shooter ◽  
Shane W. Cohen

Consumable products such as medications rely on the package or label to represent the contents. Package confusion has been widely recognized as a major problem for both over-the-counter and pharmacy-dispensed medications with potentially lethal consequences. It is critical to identify a medication as a member of a product family and differentiate its contributing elements based on visual features on the package or label. Indices that indicate degrees of commonality and differentiation of features for platforms have been shown to benefit development of engineered product families. It is possible to take a similar approach for visual features in packaging such as typography, shape/form, imagery and color. This paper establishes a commonality/differentiation index for prominence of visual features on over-the-counter and pharmacy-dispensed medications based on size and location of features. It provides a quantitative measure to assist package designers in evaluating alternatives to satisfy strategic goals and improve safety. The index is demonstrated with several medications that have been identified by the Institute for Safe Medication Practice as commonly confused.


2005 ◽  
Vol 40 (2) ◽  
pp. 117-126
Author(s):  
Michael R. Cohen

These medication errors have occurred in health care facilities at least once. They will happen again—perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them in your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the USP Medication Errors Reporting Program (MERP), which is presented in cooperation with the Institute for Safe Medication Practices. If you have encountered medication errors and would like to report them, you may call USP toll-free, 24 hours a day, at 800-233-7767 (800-23-ERROR). Any reports published by ISMP will be anonymous. Comments are also invited; the writers’ names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported through the ISMP ( www.ismp.org ) or USP ( www.usp.org ) Web sites or communicated directly to ISMP by calling 1-800-FAIL SAFE or via e-mail at [email protected] . ISMP guarantees the confidentiality and security of the information received and respects reporters’ wishes as to the level of detail included in publications.


Sign in / Sign up

Export Citation Format

Share Document